Skip to content

Author

Costanza Andriola

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Overcoming Barriers to Treatment-Free Remission (TFR) in Chronic Myeloid Leukemia (CML): Predictive Factors, Patient Selection, and Emerging Strategies to Expand Eligibility

Treatment-free remission (TFR) has become an important therapeutic goal for patients with chronic myeloid leukemia (CML) who achieve a sustained deep molecular response (DMR) on tyrosine kinase inhibitor (TKI) therapy. However, only a subset of eligible patients maintain durable remission after discontinuation, and man...

A. Laganà, Costanza Andriola, Deborah Kasmi et al. · 0 citations
Review Oct 2026

Current management and emerging pharmacotherapeutic strategies in acute promyelocytic leukemia.

INTRODUCTION Acute promyelocytic leukemia (APL) has evolved from one of the most rapidly fatal neoplasms into the most curable acute myeloid leukemia subtype, following the sequential clinical introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Despite cure rates now approaching 100% in non-high-...

A. Laganà, E. Scalzulli, M. Bisegna et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.